BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Twist Bioscience and Astellas Collaborate for Antibody Discovery in Immunotherapy

-Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sil...

April 24, 2023 | News

Patsnap Launches AI-Powered Synapse Visitor for Pharmaceutical Intelligence

Synapse is an innovative Life Sciences Platform that uses AI technology to connect Drug Discovery information with Drug Development insights. This allows p...

April 24, 2023 | News

SCG Cell Therapy to Highlight Promising Antitumor and Antiviral Activities of SCG101 in Treating HBV-Related Hepatocellular Carcinoma at ISCT

"These exciting new data being presented at ISCT continue to reinforce the potential for viral antigen specific TCR-T product to effectively treat infectio...

April 24, 2023 | News

Jim Lim joins Zühlke Group as Head of Health & Medtech in Singapore

With over 24 years of ICT industry experience, Jim brings his wealth of experience providing strategic, business and technological advice to global clients...

April 21, 2023 | News

Veeva Systems Finds Digital Content More Effective Than In-Person Meetings in Biopharma Industry

Veeva Systems (NYSE: VEEV) today released the latest Veeva Pulse Field Trends Report, the largest analysis of global healthcare professiona...

April 20, 2023 | News

Hasten Biopharma has secured a US$315 million fundraising round led jointly by CBC Group and Mubadala

CBC Group ("CBC"), Asia's largest healthcare-dedicated investment firm headquartered in Singapore, and Hasten Biopharmaceutic Company Limite...

April 20, 2023 | News

Roquette Cuts Ribbon on $25 Million Pharmaceutical Innovation Center in the United States

Staffed with a team of highly skilled research, application and formulation experts, the new $25 million center will be an advanced training and coll...

April 20, 2023 | News

Biosyngen announces FDA IND approval of its second product for EBV-positive lymphoma

A few months earlier, the Company's first product (BRG01) targeting relapsed/metastatic nasopharyngeal cancer has been granted IND approval by both the US ...

April 19, 2023 | News

Scientists from Singapore and Sweden achieve promising results towards restoring vision in blindness caused by cellular degeneration in the eye

A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplanting th...

April 17, 2023 | News

Evonik wins Asia-Pacific Bioprocessing Excellence Award for Cell Culture Solutions

The Asia-Pacific Bioprocessing Excellence Awards celebrate the latest biopharmaceutical technologies Evonik recognized for high-quality Cell Culture Sol...

April 13, 2023 | News

FINN Partners & Galen Growth will Host Digital Health Investment Summit in Boston

Digital Health Funding in Massachusetts Continues to Thrive Led by Investment in Key Therapeutic Areas Galen Growth, the...

April 12, 2023 | News

Biosyngen received China NMPA IND approval for its T-cell redirection therapy targeting EBV-positive Lymphoma

Currently, commercially available cell therapies, such as CD19 CAR-T, are designed for the treatment of B cell lymphoma or acute lymphoblastic leukemia. Tr...

April 12, 2023 | News

Partnership agreement to commercialize new anti-PD1 antibody in Australia and Southeast Asia signed by Specialised Therapeutics

The therapy ANNIKO® (penpulimab) is an anti-PD1 monoclonal antibody currently under regulatory review by the US FDA for nasopharyngeal carcinoma &...

April 12, 2023 | News

Airlangga University Hospital signs MOU with Singapore's Icon Cancer Center

As the first hospital in Indonesia to cooperate with Icon Cancer Center, Airlangga University Hospital is supporting the government's efforts to promote he...

April 10, 2023 | News

Stay Connected